Personalizing PTSD care: motivation and choice may boost recovery

NCT ID NCT06755710

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study tests whether adding a motivation-enhancing module and a shared decision-making session before standard PTSD treatment can reduce dropout and improve outcomes. Adults with PTSD at two clinics are randomly assigned to receive standard care, the motivation module plus standard care, or the motivation module plus a choice among four treatments. The goal is to see if engaging patients more actively leads to better results.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
behavioral interventions: introductory PTSD module, shared decision-making session, and standardized treatments
What this could lead to
If successful, this approach could reduce dropout rates and improve PTSD treatment outcomes by tailoring care to patient readiness and preferences.
What could go wrong
This is a behavioral study, so results may vary widely between individuals. The added sessions may not significantly improve outcomes over standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Mental Health Centre Ballerup

    RECRUITING

    Ballerup Municipality, Capital Region, 2750, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.